Haem UP 20mg Injection contains elemental iron (20mg) and is indicated for the treatment and prevention of iron deficiency anemia, particularly in patients who are unable to tolerate or absorb oral iron preparations. This parenteral iron formulation provides a rapid and effective means of replenishing iron stores, essential for hemoglobin synthesis and erythropoiesis. Haem UP 20mg Injection is administered intravenously or intramuscularly under medical supervision, ensuring controlled and precise dosing tailored to individual patient needs. It is especially beneficial in cases of chronic blood loss, malabsorption syndromes, pregnancy-related anemia, or when oral iron therapy is contraindicated or ineffective. The injection facilitates the restoration of normal hemoglobin levels and improves oxygen-carrying capacity, thereby alleviating symptoms such as fatigue, pallor, and weakness associated with iron deficiency. Adverse effects may include local pain, inflammation at the injection site, hypersensitivity reactions, and, rarely, anaphylaxis; thus, appropriate precautions and monitoring are essential during administration. Haem UP 20mg Injection should be used with caution in patients with iron overload disorders or hypersensitivity to iron products. Proper patient evaluation and periodic monitoring of hematologic parameters are recommended to optimize therapeutic outcomes and minimize potential risks.